Given that CD94/NKG2C is an activating receptor that increase NK cytotoxicity, secretion of proinflammatory cytokines, recruitment of macrophages and other inflammatory cells, it is reasonable to investigate the impact of CD94/NKG2C in autoimmune diseases. This evidence concerns the gene KLRD1 and autoimmune disease.